VC
DRUG

Vivo Capital’s Bright Minds Biosciences DRUG Stock Holding History

Vivo Capital’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40.7M Buy
557,172
+55,555
+11% +$4.47M 3.38% 10
2025
Q4 		$39.1M Hold
501,617
– – 2.53% 13
2025
Q3 		$30.4M Buy
501,617
+250,045
+99% +$9.71M 2.45% 14
2025
Q2 		$6.57M Hold
251,572
– – 0.67% 30
2025
Q1 		$9.07M Hold
251,572
– – 1.2% 18
2024
Q4 		$9.06M Buy
+251,572
New +$8.85M 1.02% 22

Other funds holding DRUG

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vivo Capital's DRUG Position: Q1 2026 in Review

Vivo Capital increased its Bright Minds Biosciences (DRUG) stake by 11% in Q1 2026, buying an estimated $4.47M and bringing the position to 557,172 shares worth $40.7M. The position accounts for 3.38% of the portfolio, ranked #10.

Vivo Capital first reported a position in DRUG in Q4 2024 and has held it in 6 quarters since. 94 funds tracked by Wall St. Rank hold DRUG as of Q1 2026.

  • Vivo Capital held 557,172 shares of Bright Minds Biosciences worth $40.7M as of Q1 2026.
  • Vivo Capital bought 55,555 Bright Minds Biosciences shares in Q1 2026, an estimated $4.47M.
  • Bright Minds Biosciences made up 3.38% of Vivo Capital's portfolio in Q1 2026, its #10 holding.
  • Vivo Capital first reported a position in Bright Minds Biosciences in Q4 2024 and has held it in 6 quarters since.
  • 94 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q1 2026.

Based on Vivo Capital's 13F filing for Q1 2026, filed 15 May 2026.